How to "Turn Back the Clock" on this $174 Billion Tech Titan
Perhaps you think it's impossible to score another 1,000% gain off this "tech titan" stock. Think again. An unusual strategy lets you virtually "recreate" gains off the biggest companies you thought had come and gone. CLICK HERE to see how it works.



Time to Bet on Casinos… Again

by The Investment U Research Team

Almost two months ago we wrote two articles on the valuations in Casino stocks MGM Mirage (NYSE: MGM) Las Vegas Sands (NYSE: LVS) and Wynn Resorts (Nasdaq: WYNN). Since then, prices have more than doubled and subsequently pulled back.

Their stock prices are resting close to the April levels we talked about in “Doubling down on Casinos” and “Bank Pullback Exposes Casino Opportunities.”

To say casinos have been on a roller coaster lately doesn’t begin to tell the whole picture. Casinos have been dealing with news of lowered traffic at Las Vegas, questionable Macau circumstances, refinancing and debt issues and a laundry list of other economic negatives.

But unlike GM or Chrysler, and perhaps the most important thing to take away from all of these tribulations, is the fact that these companies should survive. They have emerged from the worst parts of the recent storm and they will continue on.

Does that mean they’ve all emerged unscathed? No. But the fact that they have emerged is important. Because if you were to look back in 2 years without having purchased these companies you might very well be kicking yourself.

And even if you’re not interested in a two-year holding period, it took these companies a little over a month to double. We could see this exact pattern a few times before 2010. And I wouldn’t mind another 100% return (or two) before the end of the year…

Symbols mentioned in this article: MGM, LVS and WYNN.

Related Investment U Articles:



McAfee Secure sites help keep you safe from identity theft, credit card fraud, spyware, spam, viruses and online scams
Sign Up now and receive this Free report:

Contrarian Investing: Why It's Last Call for These Three Contrarian Investment Opportunities.




The Company Set to Dominate a $60 Billion-a-Year Market

$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.

The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."

Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.

Here's how you can claim your stake in the company before this cash infusion sends shares soaring.

Share Investment U:
  • email
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Google Bookmarks
  • Propeller
  • StumbleUpon
  • Technorati
  • Yahoo! Buzz
  • Reddit
  • NewsVine
  • SphereIt
  • Twitter

Comments

**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.

Check out our selection of daily Investment Research:

IU Blackboard IU Archives



Protect your purchasing power – invest in these foreign currencies and precious metals.

Recent Articles



Search Investment U





Platinum Services

Oxford Club
The Oxford Club
is an exclusive, global network of investors, who collectively participate in the pursuit of prosperity and wealth. The Club is renowned for its market-beating, tried-and-true investment principles.


White Cap The White Cap Report exclusively identifies companies, White Caps, which - by being among the earliest to gain traction - have secured dominant positions within untapped, billion-dollar markets.

A More Profitable Way to Play the Market







What Readers Are Saying…

"Always enjoy what you have to say, and learn something new (and useful) almost every time. Thanks again for your outstanding work." Jeff K.

"I just want to say a quick thank you to Alexander Green for not only his sage advise, but his reassuring words of encouragement that we all need right now." Bryan W.